Evidence map›Paper›PMID 37308215›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2023

Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review.

Étienne Gaudette, Shirin Rizzardo, Sasha B Wladyka, Tuhin Rahman, Kevin R Pothier

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Are Therapeutically Important Drugs No Longer Available in Canada?Healthcare policy = Politiques de sante · 2025
    Article
  2. Fear of missing out: Drug availability in the United States vs Canada.Journal of managed care & specialty pharmacy · 2024
    Article
  3. The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Étienne GaudetteInstitute of Health Policy Management and Evaluation (Gaudette), University of Toronto, Toronto, Ont.; Patented Medicine Prices Review Board (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont. etienne.gaudette@utoronto.ca.
Shirin RizzardoInstitute of Health Policy Management and Evaluation (Gaudette), University of Toronto, Toronto, Ont.; Patented Medicine Prices Review Board (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont.
Sasha B WladykaInstitute of Health Policy Management and Evaluation (Gaudette), University of Toronto, Toronto, Ont.; Patented Medicine Prices Review Board (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont.
Tuhin RahmanInstitute of Health Policy Management and Evaluation (Gaudette), University of Toronto, Toronto, Ont.; Patented Medicine Prices Review Board (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont.
Kevin R PothierInstitute of Health Policy Management and Evaluation (Gaudette), University of Toronto, Toronto, Ont.; Patented Medicine Prices Review Board (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug ApprovalCanadaHumans

Identifiers

PMID37308215
PMCPMC10260241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.